178 related articles for article (PubMed ID: 37964171)
1. Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.
Pannu CD; Baxter D; Anwar H
Eur Spine J; 2023 Nov; ():. PubMed ID: 37964171
[TBL] [Abstract][Full Text] [Related]
2. Spinal phosphaturic mesenchymal tumors: Case report and literature review.
Wang X; Gao J; Han S; Li Y
J Clin Neurosci; 2019 May; 63():234-239. PubMed ID: 30660478
[TBL] [Abstract][Full Text] [Related]
3. Phosphaturic mesenchymal tumors among elderly patients: a case report and review of literature.
Adnan Z; Nikomarov D; Weiler-Sagie M; Roguin Maor N
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051470
[TBL] [Abstract][Full Text] [Related]
4. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.
Hidaka N; Koga M; Kimura S; Hoshino Y; Kato H; Kinoshita Y; Makita N; Nangaku M; Horiguchi K; Furukawa Y; Ohnaka K; Inagaki K; Nakagawa A; Suzuki A; Takeuchi Y; Fukumoto S; Nakatani F; Ito N
J Bone Miner Res; 2022 Aug; 37(8):1479-1488. PubMed ID: 35690913
[TBL] [Abstract][Full Text] [Related]
5. Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway.
Hussein MAM; Cafarelli FP; Paparella MT; Rennie WJ; Guglielmi G
Radiol Med; 2021 Dec; 126(12):1609-1618. PubMed ID: 34453276
[TBL] [Abstract][Full Text] [Related]
6. Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.
Kato H; Koga M; Kinoshita Y; Hidaka N; Hoshino Y; Takashi Y; Arai M; Kobayashi H; Katsura M; Nakamoto Y; Makise N; Ushiku T; Hoshi K; Nangaku M; Makita N; Fukumoto S; Ito N
J Endocr Soc; 2022 Dec; 7(2):bvac181. PubMed ID: 36540156
[TBL] [Abstract][Full Text] [Related]
7. Tumor induced osteomalacia - A long way toward correct diagnosis and management.
Filipová L; Zikán V; Krsek M; Netuka D; Michal M; Lazúrová I
Bone Rep; 2022 Jun; 16():101180. PubMed ID: 35281212
[TBL] [Abstract][Full Text] [Related]
8. Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases.
Morimoto T; Takenaka S; Hashimoto N; Araki N; Myoui A; Yoshikawa H
Oncol Lett; 2014 Jul; 8(1):67-71. PubMed ID: 24959220
[TBL] [Abstract][Full Text] [Related]
9. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.
Ghorbani-Aghbolaghi A; Darrow MA; Wang T
Autops Case Rep; 2017; 7(3):32-37. PubMed ID: 29043208
[TBL] [Abstract][Full Text] [Related]
10. Phosphaturic mesenchymal tumor with
Dwabe S; Chow W
Ther Adv Med Oncol; 2024; 16():17588359241232092. PubMed ID: 38455709
[TBL] [Abstract][Full Text] [Related]
11. Imaging features of phosphaturic mesenchymal tumors.
Broski SM; Folpe AL; Wenger DE
Skeletal Radiol; 2019 Jan; 48(1):119-127. PubMed ID: 29987349
[TBL] [Abstract][Full Text] [Related]
12. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced osteomalacia treated with T12 tumor resection.
Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
[TBL] [Abstract][Full Text] [Related]
14. Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.
Hartley IR; Roszko KL; Li X; Pozo K; Streit J; Del Rivero J; Magone MT; Smith MR; Vold R; Dambkowski CL; Collins MT; Gafni RI
JBMR Plus; 2022 Aug; 6(8):e10661. PubMed ID: 35991529
[TBL] [Abstract][Full Text] [Related]
15. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
16. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
17. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
[TBL] [Abstract][Full Text] [Related]
19. Phosphaturic mesenchymal tumor: Clinicopathological features with outcomes in 10 patients with review of literature.
Parameshwar VC; Rekhi B; Duggad A; Ramadwar M
Indian J Pathol Microbiol; 2024 Apr; 67(2):306-311. PubMed ID: 38394416
[TBL] [Abstract][Full Text] [Related]
20.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
